Literature DB >> 26567049

Upregulation of nuclear factor-κB activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease.

Lihua Wang1, Zhiying Gao1, Lili Wang1, Yongning Gao1.   

Abstract

AIM: Chronic kidney disease (CKD) is associated with an inflammation-mediated process, and the vitamin D (3) catabolizing enzyme, CYP24, is frequently overexpressed in CKD, where it may play a crucial role in kidney disease.
METHODS: Herein, in this study, we investigated CYP24, reactive oxygen species (ROS), and inflammatory responses in an indoxyl sulfate (IS)-induced CKD model to elucidate the role of CYP24 in CKD.
RESULTS: Our results showed that IS upregulates proinflammatory cytokine, CYP24 and nuclear factor-κB (NF-κB) expression in human renal proximal tubule epithelial cells. In addition, IS treatment increased ROS production and simultaneously upregulated CYP24 expression and NF-κB translocation. Moreover, the IS-induced upregulation of CYP24 expression was alleviated by an inhibitor of NF-κB, as well as a siRNA specific to NF-κB p65. Furthermore, the renal cortex of DN (Dahl salt-resistant normotensive) + IS, DH (Dahl salt-sensitive hypertensive), and DH + IS rats showed increased expression of NF-κB p65, CYP24, 8-hydroxydeoxyguanosine (8-OHdG), a marker of ROS and macrophage infiltration compared with DN rats.
CONCLUSIONS: These results provide evidence that administration of IS in human renal tubular epithelial cells upregulates NF-κB, which leads to increase CYP24 expression and ROS production. They also suggest that suppressing NF-κB signalling is promising for the development into a strategy for CKD treatment.
© 2015 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  CYP24; chronic kidney disease; cytokine; nuclear factor-κB

Mesh:

Substances:

Year:  2016        PMID: 26567049     DOI: 10.1111/nep.12673

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

1.  Hemoglobin alters vitamin carrier uptake and vitamin D metabolism in proximal tubule cells: implications for sickle cell disease.

Authors:  Megan L Gliozzi; Youssef Rbaibi; Kimberly R Long; Dario A Vitturi; Ora A Weisz
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-11       Impact factor: 4.249

Review 2.  Role of Vitamin D in Uremic Vascular Calcification.

Authors:  Yi-Chou Hou; Wen-Chih Liu; Cai-Mei Zheng; Jing-Quan Zheng; Tzung-Hai Yen; Kuo-Cheng Lu
Journal:  Biomed Res Int       Date:  2017-02-12       Impact factor: 3.411

Review 3.  The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification.

Authors:  Yi-Chou Hou; Chien-Lin Lu; Cai-Mei Zheng; Wen-Chih Liu; Tzung-Hai Yen; Ruei-Ming Chen; Yuh-Feng Lin; Chia-Ter Chao; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

Review 4.  Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease.

Authors:  Iwona Kwiatkowska; Justyna M Hermanowicz; Michal Mysliwiec; Dariusz Pawlak
Journal:  Oxid Med Cell Longev       Date:  2020-12-29       Impact factor: 6.543

Review 5.  Phosphate, Microbiota and CKD.

Authors:  Chiara Favero; Sol Carriazo; Leticia Cuarental; Raul Fernandez-Prado; Elena Gomá-Garcés; Maria Vanessa Perez-Gomez; Alberto Ortiz; Beatriz Fernandez-Fernandez; Maria Dolores Sanchez-Niño
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

6.  The Activation of ROS/NF-κB/MMP-9 Pathway Promotes Calcium-Induced Kidney Crystal Deposition.

Authors:  Yue Wu; Jiaqiao Zhang; Cong Li; Henglong Hu; Baolong Qin; Tao Wang; Yuchao Lu; Shaogang Wang
Journal:  Oxid Med Cell Longev       Date:  2021-06-08       Impact factor: 6.543

7.  Vitamin D alleviates lead induced renal and testicular injuries by immunomodulatory and antioxidant mechanisms in rats.

Authors:  Mohammad A BaSalamah; Abdelghany Hassan Abdelghany; Mohamed El-Boshy; Jawwad Ahmad; Shakir Idris; Bassem Refaat
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.